Table 2: Patient characteristics.
Features |
Very good cytogenetics subgroup (n = 2) |
Good cytogenetics subgroup (n = 68) |
Intermediate cytogenetics subgroup (n = 40) |
Poor cytogenetics subgroup (n = 17) |
Very poor cytogenetics subgroup (n = 26) |
Median age at diagnosis (years) |
41 |
67 |
71 |
67 |
66 |
Male:Female ratio |
2:00 |
1.5:1 |
1.2:1 |
1.4:1 |
1.2:1 |
Median time of follow-up (days) |
479 |
534 |
564 |
662 |
445 |
Transplant history (with/without) |
100% (2/2) |
34% (23/68) |
25% (10/40) |
65% (11/17) |
50% (13/26) |
Mutation at initial diagnosis (with/total) |
0% (0/2) |
85% (58/68) |
93% (37/40) |
76% (13/17) |
92% (24/26) |
Evolved to overt AML (with/total) |
0% (0/2) |
16% (11/68) |
23% (9/40) |
12% (2/17) |
23% (6/26) |
Presence of germline mutations |
0% (0/2) |
4% (3/68) |
8% (3/40) |
6% (1/17) |
0% (0/26) |